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Background: Occupational chromium exposure may induce DNA damage and lead to lung cancer and other
work-related diseases. DNA repair gene polymorphisms, which may alter the efficiency of DNA repair, thus may
contribute to genetic susceptibility of DNA damage. The aim of this study was to test the hypothesis that the
genetic variations of 9 major DNA repair genes could modulate the hexavalent chromium (Cr (VI))-induced DNA
damage.
Findings: The median (P25-P75) of Olive tail moment was 0.93 (0.58–1.79) for individuals carrying GG genotype of
XRCC1 Arg399Gln (G/A), 0.73 (0.46–1.35) for GA heterozygote and 0.50 (0.43–0.93) for AA genotype. Significant
difference was found among the subjects with three different genotypes (P= 0.048) after adjusting the confounding
factors. The median of Olive tail moment of the subjects carrying A allele (the genotypes of AA and GA) was 0.66
(0.44–1.31), which was significantly lower than that of subjects with GG genotype (P= 0.043). The A allele conferred
a significantly reduced risk of DNA damage with the OR of 0.39 (95% CI: 0.15–0.99, P= 0.048). No significant
association was found between the XRCC1Arg194Trp, ERCC1 C8092A, ERCC5 His1104Asp, ERCC6 Gly399Asp, GSTP1
Ile105Val, OGG1 Ser326Cys, XPC Lys939Gln, XPD Lys751Gln and DNA damage.
Conclusion: The polymorphism of Arg399Gln in XRCC1 was associated with the Cr (VI)- induced DNA damage.
XRCC1 Arg399Gln may serve as a genetic biomarker of susceptibility for Cr (VI)- induced DNA damage.
Keywords: DNA damage, Genetic susceptibility, XRCC1, Occupational chromium exposureFindings
Background
Chromium compounds are widely used in industry as
chromium compound manufacturing, electroplating, lea-
ther tanning, welding, corrosion inhibitors, and alloying
metal, etc. The respiratory tract is the major way of oc-
cupational exposure to chromium besides oral and der-
mal exposure. Trivalent chromium(Cr(III)) compound,
an essential micronutrient, has been considered to be
lower toxicity [1]. Previous studies [2-6] have revealed
that hexavalent chromium (Cr(VI)) compounds could* Correspondence: zhuym@zju.edu.cn
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reproduction in any medium, provided the orinduce DNA damage. Exposure to Cr(VI) significantly
increases the risk of respiratory tract cancer [7,8], thus
Cr(VI) has been classified as a human carcinogen (group 1)
by the International Agency for the Research on Cancer
(IARC) [9].
Although the mechanisms involved in Cr(VI) induced
damage remains to be fully elucidated, generation of
reactive oxygen species (ROS) was likely the key step in
the intracellular reduction of Cr(VI) by cellular reduc-
tant such as reduced glutathione (GSH) and ascorbic
acid. The excessive production of ROS may lead to oxi-
dative stress, DNA damage [4,10]. Common forms of
DNA damage include DNA strand breaks, chromium-
DNA adducts, cross-links and oxidative DNA damage
[2-4,11]. However, induced DNA damage could be
repaired through individual repair system to maintainLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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DNA repair include base excision repair (BER), nucleo-
tide excision repair (NER), mismatch repair, etc. There-
fore, the residue DNA damage, which associates with
the risk of lung cancer and other diseases, is dependent
on capability of DNA repair. High inter- individual vari-
ation of DNA damage had been found in the previous
studies on chromium exposure [2,12]. Therefore, the in-
dividual DNA repair capacity might modulate the DNA
damage and associate with the risk of involved diseases
under chromium exposure. DNA repair gene polymorph-
isms, which may alter the efficiency of DNA repair, con-
tribute to genetic susceptibility of DNA damage. Hence,
we hypothesize that the genetic variation of 9 major DNA
repair genes could modulated the Cr(VI)- induced
damage and might serve as the genetic biomarkers of
susceptibility.
To examine this hypothesis, we recruited 157 chromium-
exposed electroplating workers and 93 control subjects.
DNA damage in peripheral lymphocytes was evaluated
with alkaline comet assay. Nine polymorphisms of
DNA repair genes XRCC1 Arg399Gln, XRCC1Arg194Trp,
ERCC1 C8092A, ERCC5 His1104Asp, ERCC6 Gly399Asp,
GSTP1Ile105Val, OGG1 Ser326Cys, XPC Lys939Gln, XPD
Lys751Gln were determined. The associations between
these polymorphism markers and the Cr (VI)- induced
DNA damage were analyzed.Materials and Methods
Study subjects
157 electroplating workers were recruited from 20 elec-
troplating factories in Hangzhou, China from 2009–
2010. Control subjects (n = 93) were recruited from the
workers without exposure to chromium compounds and
other known physical or chemical genotoxic agents. Sub-
jects with abnormal liver or kidney function and suffer-
ing from other chronic diseases such as cancers,
diabetes, heart diseases were excluded in the study. All
the subjects were interviewed for information of age,
smoking habits, alcohol consumption, medical history
and years of chromium exposure. Short- term sampling
of air was conducted according to Specifications of Air
Sampling for Hazardous Substances Monitoring in the
Workplace in China (GBZ159-2004). Airborne chro-
mium concentration was measured by graphite furnace
atomic absorption spectrophotometer (M6 Thermo,
USA). About 4 ml of peripheral vein blood sample was
collected from each subject and drawn into two vacuum
tubes containing 3.6 mg of EDTA. 2 ml of blood was
stored at 4°C for determining chromium levels and the
comet assay, and the other was stored at −80°C for DNA
isolation and genotyping. The study protocol was
approved by the Institutional Review Board of HangzhouCenter for Disease Control and Prevention. Written
informed consent was obtained from each subject.
DNA damage determination
The alkaline comet assay was employed to detect the
DNA damage in peripheral lymphocytes. The alkaline
comet assay was performed as previously described with
some modifications [13]. Peripheral blood (10 μl) was
mixed with 75 ul of 0.75% low-melting- point agarose
and transferred to a microscope slide pre-coated with a
layer of 0.75% normal-melting-point agarose. The slides
were immersed in the lysis buffer (2.5 mol/L NaCl,
100 mmol/L EDTA, 10 mmol/L Tris, freshly added 1%
Triton X-100 and 10% DMSO, pH 10) for 1 h at 4°C to
remove proteins. The slides were then placed in a hori-
zontal electrophoresis tank containing electrophoresis
buffer (300 mmol/L NaOH, 1 mmol/L EDTA, pH 13)
for 20 min to allow DNA unwinding. The electrophor-
esis was carried out in the same buffer for 20 min. After
electrophoresis, the slides were neutralized in the
neutralization buffer (0.4 mol/L Tris, pH 7.5), and then
stained with 50 μL ethidium bromide solution (20 μg/mL).
All the steps were conducted under yellow light to pre-
vent additional DNA damage. One hundred nuclei
were selected randomly from each sample. The ob-
servation was made at 400× magnification using a
fluorescence microscope (DMI 4000) equipped with
a 530-nm excitation filter and a computer-based
image analysis program CASP. The medians of Olive
tail moment, tail length and tail DNA% were used
for assessing DNA damage. Olive tail moment is
defined as the product of the tail length and the
fraction of total DNA in the tail and calculated as
[(tail mean - head mean) × (tail DNA%/100)] [13].
Genotyping
DNA was extracted from peripheral lymphocytes using
genomic DNA extraction kits (Tiangen blood genomic
DNA extraction kits, Tiangen, China). The genotypes of
XRCC1 Arg194Trp and Arg399Gln were determined
with PCR-RFLP. The primers of amplification were as
follows: XRCC1 Arg194Trp:F: 5′-GCC CCG TCC CAG
GTA-3′,R: 5′-AGC CCC AAG ACC CTT TCA CT-
3′;XRCC1 Arg399Gln:F: 5′-TTG TGC TTT CTC TGT
GTC CA-3′,R: 5′-TCC TCC AGC CTT TTC TGA TA-
3′. PCR for XRCC1 Arg194Trp and XRCC1 Arg399Gln
were performed under the following conditions: 95°C for
5 min, followed by 30 cycles of 94°C for 40s, 56°C
(Arg399Gln) or 61 °C (Arg194Trp) for 30 s and 72°C for
30 s and a final elongation step at 72°C for 10 min. Then
the PCR products were digested at 37°C for 12 h with
restricted endonucleases MspI (NEB, USA) (Arg399Gln)
or PvuII (Arg194Trp). The 10 μL of digested PCR pro-
ducts were electrophoresed on a 2% agarose gel. For
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bands (375 bp and 240 bp) represent arg/arg, and three
bands (615 bp, 375 bp and 240 bp) represent arg/gln.
For Arg194Trp, one band of 491 bp represents arg/arg,
two bands (197 bp and 294 bp) represent trp/trp, and
three bands (197 bp, 294 bp and 491 bp) represent arg/gln.
The genotypes of ERCC1 C8092A, ERCC5 His1104Asp,
ERCC6 Gly399Asp, GSTP1Ile105Val, OGG1 Ser326Cys,
XPC Lys939Gln, XPD Lys751Gln were detected using
TaqMan probe- based real time PCR (7900, ABI, USA).
The primer and probe sequences were obtained from
the National Cancer Institute’s SNP500Cancer database.
Negative controls and previously genotyped samples
were included in each plate to ensure the accuracy of
the genotyping.Statistical analysis
Because distribution of DNA damage data (olive tail mo-
ment, tail length and tail DNA%) do not follow normal
distribution, the median and P25-P75 was used to
summarize the central location and variation of data,
and compared among genotype groups using non-
parametric test (Kruskal-Wallis test). Chi square test was
used to compare frequency data. A goodness-of-fit Chi
square test was used to evaluate for the Hardy-Weinberg
equilibrium. Multivariate linear (the DNA damage data
was square root-transformed) and logistic models were
used to adjust the potential confounding variables in-
cluding age, gender, smoking status, drinking and occu-
pational exposure time of chromium. A two-sided P
value of less than 0.05 was considered statistically signifi-
cant. All statistical calculations were performed by using
SPSS 16.0.Results
Characteristics of the study population
The mean age (± standard deviation) of exposed subjects
was 39.7 ± 8.3 years while 38.8 ± 9.6 years for control
group (P> 0.05). There were no significant differences
in gender, smoking status, alcohol consumption between
the two groups (all P values> 0.05). The median time of
chromium exposure was 5.3 years (range: 0.5 to
23 years).Table 1 The chromium concentration in erythrocytes (μg/l) an
Exposed subje
chromium concentration in erythrocytes (μg/l) 4.41 (2.50–5.29)
Olive tail moment 1.13 (0.47–1.45)
Tail Length 11.77 (6.42–14.8
Tail DNA% 3.69 (2.50–5.29)
1. Data were presented as median (P25-P75).
2. P values were calculated with rank sum test between the exposed and control su
3. Owing to missing detect in DNA damage and genotype, the numbers of subjectsThe median of short-term exposure concentration of
chromium in the air at the 20 electroplating workplaces
was 0.060 mg/m3 (range from 0.016 to 0.531 mg/m3),
which was higher than the permissible concentration
short term exposure limit (PC-STEL) of chromium in
China (0.05 mg/m3), and 52% factories had chromium
level above the standard of PC-STEL.
The chromium concentration in erythrocytes and DNA
damage in exposed and control subjects
Chromium concentrations in erythrocytes and DNA
damage in exposed and control groups were shown in
Table 1. The exposed subjects had the median (P25-P75)
of chromium concentration in erythrocytes of 4.41 μg/l
(2.50, 5.29), which was about two times higher than that
in control subjects (1.54 μg/l (0.61–2.98), P< 0.001).
The medians of Olive tail moment, tail length and tail
DNA% in exposed group were 1.13(0.47–1.45), 11.77
(6.42–14.84) and 3.69 (2.50–5.29), respectively, and were
significantly higher than those in control subjects (0.12
(0.04–0.22), 3.26 (3.00–4.00) and 0.59 (0.19–1.11)
(P< 0.001).
Genotypes of the polymorphism of XRCC1 Arg399Gln and
the DNA damage induced by Cr (VI) exposure
The allele frequencies for XRCC1 399Gln, XRCC1
194Trp, OGG1 326Cys, ERCC1 8092A, ERCC5
1104Asp, ERCC6 399Asp, XPD 751Gln, XPC 939Gln,
GSTP1105Val were 0.24, 0.24, 0.54, 0.57, 0.49, 0.46, 0.08,
0.38, 0.16, respectively. Genotype distributions of all the
polymorphisms studied were all consistent with Hardy-
Weinberg equilibrium (P> 0.05). The medians and P25-
P75 of Olive tail moment, tail length and tail DNA% in
the subjects with different genotypes were shown in
Table 2.
The median of Olive tail moment (P25–P75) was 0.93
(0.58–1.79) for individuals carrying GG genotype of
XRCC1 Arg399Gln (G/A), 0.73 (0.46–1.35) for GA het-
erozygote and 0.50 (0.43–0.93) for AA genotype, respect-
ively. After adjusting the confounding factors of gender,
smoking status, drinking and occupational exposure time
of chromium, significant difference in Olive tail moment
was found among the subjects with different genotypes
(P=0.048). The median of Olive tail moment of thed DNA damage in exposed and control subjects
cts n= 149 Control subjects n= 77 P valuea
1.54 (0.61–2.98) <0.001
0.12 (0.04–0.22) <0.001
4) 3.26 (3.00–4.00) <0.001
0.59 (0.19–1.11) <0.001
bjects.
in Table 2 were less 157 in exposed group and 93 in control group.
Table 2 DNA damage in the exposed subjects with different genotypes of polymorphisms
SNP genotype n Olive tail moment Tail length Tail DNA%
Median P25-P75 Median P25-P75 Median P25-P75
XRCC1 Arg399Gln GG 70 0.93 0.58–1.79 9.74 6.89–18.14 3.25 1.94–5.58
GA 42 0.73 0.46–1.35 8.19 5.93–13.79 2.50 1.77–4.36
AA 8 0.50 0.43–0.93 6.64 5.00–9.92 1.91 1.43–3.03
P* 0.048 0.050 0.039
AA+GA 50 0.66 0.44–1.31 8.00 5.69–13.74 2.32 1.66–4.33
P∮ 0.043 0.067 0.046
XRCC1 Arg194Trp CC 66 0.75 0.47–1.45 8.55 6.30–14.22 2.82 1.66–4.85
CT 49 0.91 0.48–1.49 9.69 6.97–16.25 3.22 1.83–4.75
TT 5 0.66 0.37–1.82 7.67 5.11–16.94 2.39 1.29–5.84
P* 0.973 0.964 0.992
OGG1 Ser326Cys CC 18 1.09 0.41–1.84 11.72 4.92–18.87 3.63 1.55–5.80
CG 56 0.86 0.47–1.46 9.18 6.50–15.53 3.07 1.73–4.86
GG 41 0.78 0.56–1.19 8.93 6.87–12.07 2.69 2.02–4.15
P* 0.462 0.335 0.377
ERCC1 C8092A CC 20 0.84 0.45–1.38 9.79 6.56–15.53 3.20 1.77–4.72
CA 47 0.71 0.47–1.43 8.10 5.81–14.10 2.45 1.61–4.53
AA 49 0.92 0.62–1.60 9.66 7.21–17.29 3.22 2.06–5.50
P* 0.543 0.690 0.595
ERCC5 His1104Asp GG 25 0.92 0.62–1.60 9.66 7.21–17.29 3.22 2.06–5.50
GC 61 0.84 0.54–1.50 9.66 6.79–15.88 2.84 1.99–4.99
CC 30 0.83 0.50–1.38 9.21 7.01–15.05 3.04 1.81–4.59
P* 0.886 0.931 0.920
ERCC6 Gly399Asp CC 32 0.83 0.49–1.14 8.90 6.82–11.70 3.03 1.87–3.97
CT 54 0.75 0.48–1.73 8.26 6.42–16.12 2.75 1.85–5.51
TT 31 1.03 0.48–1.57 10.70 5.72–18.10 3.22 1.68–5.19
P* 0.143 0.152 0.203
XPD Lys751Gln AA 94 0.82 0.48–1.45 9.50 6.42–14.84 2.94 1.81–4.80
AC 20 0.81 0.48–1.81 8.79 7.00–16.74 2.88 1.88–5.81
CC 0
P* 0.771 0.742 0.900
XPC Lys939Gln GG 45 0.89 0.56–1.52 9.66 6.97–15.96 2.96 2.02–5.14
GT 53 0.83 0.47–1.40 8.87 6.63–14.07 2.75 1.39–6.13
TT 18 0.81 0.39–2.10 9.13 5.68–23.00 2.92 1.73–4.57
P* 0.564 0.379 0.705
GSTP1 Ile105Val AA 80 0.83 0.52–1.58 9.21 6.75–15.65 2.94 1.85–5.30
AG 30 0.70 0.38–1.41 8.03 5.71–15.29 2.41 1.62–4.53
GG 6 1.02 0.71–1.84 11.89 8.83–18.95 3.74 2.46–5.83
P* 0.169 0.514 0.463
* The DNA damage data was square root-transformed and multivariable linear model was used after adjusting confounding factors of gender, age, smoking
status, drinking and exposure time of chromium.
∮ Comparing the subjects with GG genotype with AA+GA.R
Owing to missing detect in DNA damage and genotype, the numbers of subjects in Table 2 were less 157 in exposed group.
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Figure 1 The percentage of high DNA damage in different
genotypes of XRCC1 399. DNA damage was quantitatively
assessed with Olive tail moment by alkaline comet assay. High DNA
damage was defined as great than the value (1.44) of percentile 75
of Olive tail moment.
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was 0.66 (0.44–1.31), which was significantly lower than
that for those with GG genotype (P=0.043).
Similar results were observed for tail length and tail
DNA% in different groups. After adjustment of the po-
tential confounding factors, significant differences were
found in tail length (P= 0.050) and tail DNA%
(P= 0.039) among different genotypes. The medians of
tail length were 9.74 (6.89–18.14) for individuals carry-
ing GG genotype in XRCC1 Arg399Gln (G/A), 8.19
(5.93–13.79) for GA heterozygote and 6.64 (5.00–9.92)
for AA genotype, respectively. The medians of tail DNA
% were 3.25 (1.94–5.58) for individuals carrying GG
genotype of XRCC1 Arg399Gln (G/A), 2.50 (1.77–4.36)
for GA heterozygote and 1.91 (1.43–3.03) for AA geno-
type, respectively. The median of tail DNA% of the sub-
jects with carrying A allele (the genotypes of AA and
GA) was 2.32 (1.66–4.33), which was significantly lower
than that for those with GG genotype (P= 0.046). A bor-
derline statistical difference was found in tail length
when compared the subjects carrying A allele with GG
genotype (P= 0.067).
No statistical association in Olive tail moment, tail
length and tail DNA% was found among different geno-
types of XRCC1 Arg194Trp, ERCC1 C8092A, ERCC5
His1104Asp, ERCC6 Gly399Asp, GSTP1 Ile105Val,
OGG1 Ser326Cys, XPC Lys939Gln, XPD Lys751Gln (all
the P value >0.05).
With the 75th percentile of Olive tail moment (1.44)
as a cut-off point, the subjects were divided into two
groups: high DNA damage (>1.44) and low DNA dam-
age (≦1.44). 31.4% (22/70) of the subjects carrying GG
genotype of XRCC1 Arg399Gln (G/A) had higher DNA
damage (>1.44 of olive tail moment) while only 16.0%
(8/50) in the subjects carrying A allele. Dose- response
relationship was found between the number of A allele
and DNA damage (Ptrend adjusted = 0.031). Comparing
with the subjects with genotypes of GG, the subject car-
rying A allele was significantly associated with the
reduced risk of DNA damage with the odds ratio of
0.388 (95% CI: 0.152–0.992, P= 0.048) after adjusting the
potential confounders of gender, smoking status, drink-
ing and exposure time of chromium (Figure 1).
Discussion
In the present study, we found the chromium concentra-
tion in erythrocytes was found to be significantly higher in
electroplating workers (4.41 μg/l) than that in control sub-
jects. The finding indicated there was hexavalent chro-
mium exposure in electroplating workplace. Occupational
chromium exposure in electroplating induced DNA dam-
age. We also found that the polymorphisms of XRCC1
Arg399Gln was associated with Cr(VI)- induced DNA
damage. Our findings supported the hypothesis that thegenetic variation of major DNA repair genes could modu-
late the Cr (VI)- induced damage. The DNA repair cap-
acity may associate with the risk of chromium exposure
induced disease such as lung cancer and XRCC1
Arg399Gln could be served as a genetic biomarker of sus-
ceptibility for chromium exposure.
Cr (VI) compound can actively enter into the cells
through the isoelectric and isostructural anion chan-
nels [5], phagocytosis [14], et al. Once inside the cell
and in the presence of cellular reductants, such as as-
corbate and thiols, Cr (VI) compounds can be
reduced through short-lived Cr intermediates (Cr (V)
and Cr (IV)) to the stable trivalent state Cr (III) [15].
During these reactive processes, reactive oxygen spe-
cies (ROS) such as hydroxyl radicals, single oxygen,
superoxide and hydrogen peroxide, were generated.
The resulting excessive production of ROS may lead
to oxidative damage, DNA adducts and crosslinks
[16,17]. Iarmarcovai et al. [18]. found the binucleated
micro-nucleated cell rate in chromium-exposed weld-
ing worker was significantly higher than in control
subjects. In the previous study [2], we found the Cr
(VI) exposed electroplating workers had higher con-
centrations of 8-OHdG (an indicator of oxidative
DNA damage), olive tail moment, tail length and tail
DNA% which were evaluated by comet assay. These
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studies [3,19]. Therefore, Cr (VI) is a genotoxic agent
and associated the risk of lung cancer and other oc-
cupational diseases [15].
The DNA repair mechanisms are responsible for
repairing the xenobiotic induced DNA damage and
maintaining the genomic stability. DNA repair system is
involved in the repair of Cr (VI)- induced DNA lesion
such as Oxidative damage and single strand break, which
are the main forms of DNA damage. Base excision repair
(BER) pathway is mainly responsible for repair these DNA
lesions. X-ray repair cross-complementing group 1(XRCC1)
is a key component in repairing both direct SSB and indir-
ect SSB generated indirectly during base excision re-
pair [20]. It serves as a scaffold connecting many of
the other proteins involved in SSB repair. XRCC1 is
recruited to SSBs by poly(ADP-ribose)polymerase
(PARP1) and then interacts with a number of im-
portant proteins involved in SSB such as proliferat-
ing cell nuclear antigen (PCNA), DNA polymerase
beta (Polb), and polynucleotide kinase (PNK) [20,21].
XRCC1 was essential to reduce the formation of lead chro-
mate induced chromatid lesions [22]. XRCC1 protein is
involved in the repair of Cr(VI)-induced SSB [23] and in
protection from lead chromate–induced chromosome in-
stability [22].
Genetic polymorphisms of key proteins might be
involved in inter-individual variations of DNA repair
processes and influence the extent of genotoxic damage.
XRCC1 Arg399Gln, a functional genetic variation, may
alter the capacity of XRCC1 to interact with several act-
ing enzymes and associated with the efficiency of BER
repair [24,25]. Many previous studies [26-28] revealed
XRCC1 Arg399Gln was associated with the common
cancers such as lung, bladder, esophageal cancers, etc.
and modulated the cancer risk for common environmen-
tal exposure. In chromium-exposed electroplating work-
ers, we found the polymorphism of XRCC1 Arg399Gln
was associated the Olive tail moment, tail length and tail
DNA%. The subject carrying A allele reduced the risk of
high DNA damage. In the previous studies, XRCC1
Arg399Gln was also found to be associated with
chromosome aberrations [29] and micronuclei [18,30] in
the chromium exposed welding worker. This poly-
morphism was also found to modulate the risk of DNA
damage induced other occupational exposure to DNA
damage agents such as vinyl chloride [31], asbestos [32]
and 1,3-butadiene [33].
However, we didn’t find significant association between
XRCC1 Arg194Trp and the Cr (VI)-induced DNA dam-
age. This finding was inconsistent with the previous stud-
ies [31,33]. We also failed to find any associations of the
polymorphisms of ERCC1 C8092A, ERCC5 His1104Asp,
ERCC6 Gly399Asp, GSTP1 Ile105Val, OGG1 Ser326Cys,XPC Lys939Gln, XPD Lys751Gln with the DNA lesions.
One of the possible reasons might be the specific effect of
the DNA repair proteins responding to Cr (VI)-induced
DNA damage. The other might be small sample size and
relative low statistical power of test in this study. Only
122 chromium exposed electroplating workers were
studied and false negative results might exist. Therefore,
further study is required with large sample size and
more statistical power to screen new genetic biomarkers
of Cr (VI)-induced DNA damage.
In conclusion, we found that the genetic variation of
XRCC1 Arg399Gln was associated with the Cr (VI)-induced
DNA damage. XRCC1 Arg399Gln may be served as a
genetic marker of susceptibility and high risk individual
identification for chromium exposed workers. With this
genetic biomarker, the susceptible population could be
screened and prevent from chromium exposure.
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